CN108236043A - A kind of symphysis unit feed addictive containing stachyose - Google Patents
A kind of symphysis unit feed addictive containing stachyose Download PDFInfo
- Publication number
- CN108236043A CN108236043A CN201611202094.6A CN201611202094A CN108236043A CN 108236043 A CN108236043 A CN 108236043A CN 201611202094 A CN201611202094 A CN 201611202094A CN 108236043 A CN108236043 A CN 108236043A
- Authority
- CN
- China
- Prior art keywords
- stachyose
- feed addictive
- animal
- symphysis unit
- inulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 title claims abstract description 41
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 title claims abstract description 41
- 229920001202 Inulin Polymers 0.000 claims abstract description 20
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 20
- 229940029339 inulin Drugs 0.000 claims abstract description 20
- 229910052802 copper Inorganic materials 0.000 claims abstract description 19
- 239000010949 copper Substances 0.000 claims abstract description 19
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 16
- -1 copper amino acid Chemical class 0.000 claims abstract description 16
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 15
- 239000013522 chelant Substances 0.000 claims abstract description 15
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 14
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 14
- 241000235342 Saccharomycetes Species 0.000 claims abstract description 14
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 14
- 239000012138 yeast extract Substances 0.000 claims abstract description 14
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 claims abstract description 13
- 229920001543 Laminarin Polymers 0.000 claims abstract description 13
- 239000005717 Laminarin Substances 0.000 claims abstract description 13
- RWMKSKOZLCXHOK-UHFFFAOYSA-M potassium;butanoate Chemical compound [K+].CCCC([O-])=O RWMKSKOZLCXHOK-UHFFFAOYSA-M 0.000 claims abstract description 13
- 235000015099 wheat brans Nutrition 0.000 claims abstract description 12
- 108010059892 Cellulase Proteins 0.000 claims abstract description 7
- 108091005804 Peptidases Proteins 0.000 claims abstract description 7
- 239000004365 Protease Substances 0.000 claims abstract description 7
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 7
- 229940106157 cellulase Drugs 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 101000906492 Arabidopsis thaliana Endoglucanase 1 Proteins 0.000 claims description 4
- 101710180319 Protease 1 Proteins 0.000 claims description 4
- 101001036014 Ruminiclostridium josui Endoglucanase 2 Proteins 0.000 claims description 4
- 101710137710 Thioesterase 1/protease 1/lysophospholipase L1 Proteins 0.000 claims description 4
- 241000207923 Lamiaceae Species 0.000 claims description 2
- 241000013557 Plantaginaceae Species 0.000 claims description 2
- 235000021374 legumes Nutrition 0.000 claims description 2
- 241000304886 Bacilli Species 0.000 claims 1
- 241000282849 Ruminantia Species 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003337 fertilizer Substances 0.000 claims 1
- 239000002023 wood Substances 0.000 claims 1
- 241001465754 Metazoa Species 0.000 abstract description 30
- 230000003115 biocidal effect Effects 0.000 abstract description 8
- 230000000968 intestinal effect Effects 0.000 abstract description 6
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 229940118199 levulan Drugs 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 235000013406 prebiotics Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 230000005784 autoimmunity Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 108010091371 endoglucanase 1 Proteins 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- FLDFNEBHEXLZRX-DLQNOBSRSA-N Nystose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FLDFNEBHEXLZRX-DLQNOBSRSA-N 0.000 description 1
- 101710180316 Protease 2 Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000010065 bacterial adhesion Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003538 tetroses Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Fodder In General (AREA)
Abstract
The present invention relates to a kind of symphysis unit feed addictive containing stachyose, which is matched by following weight parts：Yeast extract 15 35, inulin 10 22, laminarin 10 20, potassium butyrate 8 18, wheat bran 4 17, stachyose 18, cellulase 13, kilnitamin 13, protease 12, copper amino acid chelate 0.5 3, bacillus subtilis (containing Bacillus acidi lactici, Bifidobacterium, saccharomycete) 0.05 3.5.The characteristics of feed addictive, is：Natural stachyose and inulin are selected, while is equipped with a kind of symphysis unit feed addictive made of bacillus subtilis (containing Bacillus acidi lactici, Bifidobacterium, saccharomycete).The feed addictive can quickly improve the intestinal flora environment of animal (non-to ruminate), improve the immunity of animal, promote growth of animal；The use of antibiotic and hormone in animal feeding can be reduced, improves product quality and quality, reduces pollution of the animal feeding to environment.
Description
Technical field
This discovery is related to a kind of feed addictive more particularly to a kind of symphysis unit feed addictive containing stachyose.
Background technology
The discovery of 20 middle of century, antibiotic etc. and the success of chemical antibacterial material synthesis, make first in mankind's input
With being then widely used as feed addictive, important function played in animal health and husbandry sector.But due to these
The long-time service of additive and abuse, drawback increasingly obtain the extensive understanding of people：1. antibiotic animal products meat,
It remains, is detrimental to health in egg, milk, hair, skin, such as generate " three cause ", allergy or even generate the current scientific level of the mankind also
The disease or potential hazard that not will appreciate that.2. the microorganism of livestock and poultry inside and outside is caused to generate drug resistance or drug resistance to antibiotic,
Drug effect reduces, and dosage is continuously increased, and aquaculture cost is made also to make medicament residue even more serious while being continuously increased, and is formed pernicious
Cycle.3. it after livestock and poultry long-time service or abuse of antibiotics, while pathogenic microorganisms is inhibited, also kills normal in animal body
Beneficial microorganism species, make the normal Tiny ecosystem system of body unbalance, cause animal autogenous infection or suprainfection.4. make
Livestock and poultry generate dependence to antibiotic, inhibit the growth and development of animal immune system or reduce the immune function of animal, make disease-resistant
Ability is greatly reduced.
For various drawbacks that antibiotic etc additive is overcome to bring, the scientist of countries in the world also just makes great efforts to seek
The novel fodder additive having no toxic side effect with exploitation.Probiotics are just with its is green safe, have no toxic side effect, noresidue
Advantage gradually becomes the main force of substitute antibiotics class additive, however influences probiotics and play the factor of its effect very
It is more, preparation method, holding conditions including preparation, pollution (such as miscellaneous bacteria), survival rate, incorrect product strain combination mode,
State, dosage and the number of intestinal flora, the change at the age of animal (host), survival rate, feed ingredient in enteron aisle
Change, physiological status etc..Therefore, a kind of additive that antibiotic can be replaced to can effectively improve animal microecological system again is developed to compel
In the eyebrows and eyelashes.
Stachyose (stachyose) is a kind of natural tetrose existing for nature, be the glucosyl group side of sucrose with
The carbohydrate that 1,6 glycosidic bond is formed with reference to 2 α-galactolipins, molecular formula C24H42O21, molecular weight 666.59.Stachyose
It is the natural component extracted from Labiatae, Scrophulariaceae and legume, is a kind of natural super bifidobacterium, can be proliferated rapidly
The profitable strain of animal intestinal tract.
Inulin is the mixture of a kind of natural levulan.Levulan is fructose units formed by the connection of (2-1) chain and with
The average degree of polymerization of levulan is 10-30 in the usual commercialization inulin of carbohydrate that glucose unit terminates, wherein containing
A small amount of oligofructose.The presence of inulin can be found in almost all of plant, it is the another kind of the plant in addition to starch
We from jerusalem artichoke plant extract and are refining to obtain inulin product the form of energy storage, and the degree of polymerization is from more kinds of levulan of 2-60
Mixture, inulin is also a kind of prebiotics for the profitable strain that can be proliferated animal intestinal tract.
Invention content
The object of the present invention is to provide a kind of symphysis unit feed addictive containing stachyose, be using stachyose and inulin as
Profitable strain proliferation factor, and the symphysis that addition bacillus subtilis is coordinated to be formed (containing Bacillus acidi lactici, Bifidobacterium, saccharomycete)
First additive, while also add in yeast extract, laminarin, potassium butyrate, wheat bran, cellulase, kilnitamin, albumen
Symphysis unit feed addictive containing stachyose made of enzyme, copper amino acid chelate mixture manufacturing.The symphysis unit containing stachyose is raised
Feed additives while can also improve animal itself and exempt from the use for improving micro-ecological environment, substitute antibiotics in animal body
Epidemic disease power improves effect of the animal to various nutrient absorptions.
Symphysis unit feed addictive provided by the invention containing stachyose is prepared by the component that following weight parts match：
Yeast extract 15-35, inulin 10-22, laminarin 10-20, potassium butyrate 8-18, wheat bran 4-17, stachyose 1-8, cellulose
Enzyme 1-3, kilnitamin 1-3, protease 1-2, copper amino acid chelate 0.5-3, bacillus subtilis is (containing Bacillus acidi lactici, bifid
Bacillus, saccharomycete) 0.05-3.5.
Preferred weight part of each component of the symphysis unit feed addictive containing stachyose of the preparation present invention, which matches, is：Yeast
Extract 20-35, inulin 15-20, laminarin 15-20, potassium butyrate 8-15, wheat bran 6-14, stachyose 3-7, cellulase 1-
2, kilnitamin 1-2, protease 1-2, copper amino acid chelate 1-2, bacillus subtilis is (containing Bacillus acidi lactici, Bifidobacterium, ferment
Female bacterium) 0.5-2.
Optimum weight part of each component of the symphysis unit feed addictive containing stachyose of the preparation present invention, which matches, is：Yeast
Extract 25, inulin 20, laminarin 18, potassium butyrate 12, wheat bran 10, stachyose 6, cellulase 2, kilnitamin 2, albumen
Enzyme 1, copper amino acid chelate 1.5, bacillus subtilis (containing Bacillus acidi lactici, Bifidobacterium, saccharomycete) 1.5.
Said components room temperature is uniformly mixed by the above-mentioned symphysis unit feed addictive containing stachyose by conventional blending processes
It can be used.
The effect of each component of the present invention：Stachyose is known as " super bifidobacterium ", can significantly increase the competing of profitable strain
Strive advantage.Stachyose can effectively be proliferated intestinal beneficial microbes, harmful bacteria can be blocked to stick intestinal mucosa.Due to many diseases
There is lectin on the surface of pathogenic microorganism, can be specifically bound with enteric epithelium oligosaccharide acceptor, make bacterial adhesion in intestinal wall simultaneously
Proliferation, leads to intestines problem, and the structure of some oligosaccharides is similar to enteric epithelium oligosaccharide acceptor, can be coagulated with the external source of pathogen
Collection element specific binding, prevents pathogen from sticking in intestinal wall, and is excreted with oligosaccharides.It is added in animal feed prebiotic
Member can improve the speed of growth of animal, improve efficiency of feed utilization, disease preventing and treating, the autoimmunity for improving animal.Withered grass gemma
Bacillus can quickly supplement the profitable strain in animal body (containing Bacillus acidi lactici, Bifidobacterium, saccharomycete), with stachyose and inulin
Complementation collaboration improves the microecosystem in animal body.Yeast extract has the somatotrophic effect of food calling, has and promotes enteron aisle hair
It educates, reduces diarrhea, improves the effect of immune function and the effect of resisting stress.Butyrate is a kind of short-chain fat hydrochlorate, in daily ration
Addition butyrate can improve the feed intake of animal by improving feed flavor, influence the development of animal gastrointestinal tract and enteron aisle digestion
The activity of enzyme.Copper amino acid chelate can mitigate the antagonism of copper and other nutriments, promote copper and other mineral matter elements
It is absorbed and utilized, reduces since copper bar puts pollution on the environment, reduce since copper antagonism is to nutritional ingredients other in feed
Destroy etc..Copper amino acid chelate also has the growth and development for promoting animal, improves efficiency of feed utilization, improves carcass quality, improves
Reproductive performance, while also there is antibiooxidation, adjust endocrine and a series of functions such as immune.Protease is added in feed
It is intended to increase dietary protein hydrolysis, and then improve the utilization of daily ration nitrogen.When animal preferably can utilize nitrogen, we are just
The protein content in daily ration can be reduced, this transfers just to reduce the nitrogen content in excrement.Cellulase can be supplemented in animal body
The deficiency of various endogenous digestive ferments reduces the generation of disease of digestive tract, and the digestion of the nutriments such as protein, starch is promoted to inhale
It receives.
It is characteristic of the invention that using stachyose, inulin as main prebiotics, and it is equipped with bacillus subtilis (bar containing lactic acid
Bacterium, Bifidobacterium, saccharomycete) composition symphysis unit feed addictive, and it is aided with yeast extract, laminarin, potassium butyrate, bran
Feed addictive made of the components such as skin, cellulase, kilnitamin, protease, copper amino acid chelate.Its prescription science is closed
Reason, effect collaboration are ensured that animal intestinal micro-ecology is balanced by multipath, promote the raising of animal autoimmunity at many levels
With the absorption to various nutritional ingredients, be provided in particular in antibiotic alternative solution, both reduced aquaculture cost have can reduce it is foster
Grow the pollution to environment.
Specific embodiment
A part of specific embodiment is set forth below, and the present invention is further described, it is necessary to be pointed out that example in detail below
Only the present invention will be further described, does not represent limiting the scope of the invention.Other people make according to the present invention
Some nonessential modifications and adjustment still belong to protection scope of the present invention.
Embodiment 1：
The component system that the symphysis unit feed addictive containing stachyose that the embodiment of the present invention 1 provides is matched by following weight parts
It is standby to form：Yeast extract 21, inulin 18, laminarin 18, potassium butyrate 18, wheat bran 15, stachyose 5, cellulase 2, mixing
Amino acid 1, protease 2, copper amino acid chelate 1, bacillus subtilis (containing Bacillus acidi lactici, Bifidobacterium, saccharomycete) 1.
Embodiment 2：
The component system that the symphysis unit feed addictive containing stachyose that the embodiment of the present invention 2 provides is matched by following weight parts
It is standby to form：Yeast extract 18, inulin 15, laminarin 20, potassium butyrate 10, wheat bran 15, stachyose 2, cellulase 1, mixing
Amino acid 1, protease 1, copper amino acid chelate 1, bacillus subtilis (containing Bacillus acidi lactici, Bifidobacterium, saccharomycete) 0.08.
Embodiment 3：
The component system that the symphysis unit feed addictive containing stachyose that the embodiment of the present invention 3 provides is matched by following weight parts
It is standby to form：Yeast extract 22, inulin 18, laminarin 15, potassium butyrate 10, wheat bran 10, stachyose 5, cellulase 1, mixing
Amino acid 1, protease 1, copper amino acid chelate 2, bacillus subtilis (containing Bacillus acidi lactici, Bifidobacterium, saccharomycete) 2.
Embodiment 4：
The component system that the symphysis unit feed addictive containing stachyose that the embodiment of the present invention 4 provides is matched by following weight parts
It is standby to form：Yeast extract 20, inulin 20, laminarin 18, potassium butyrate 12, wheat bran 10, stachyose 6, cellulase 2, mixing
Amino acid 1, protease 1, copper amino acid chelate 1.5, bacillus subtilis (containing Bacillus acidi lactici, Bifidobacterium, saccharomycete) 1.5.
Claims (5)
1. a kind of symphysis unit feed addictive containing stachyose, it is characterised in that the feed addictive is matched by following weight parts
Component is prepared：Yeast extract 15-35, inulin 10-22, laminarin 10-20, potassium butyrate 8-18, wheat bran 4-17, wood
Sugared 1-8, cellulase 1-3, kilnitamin 1-3, protease 1-2, copper amino acid chelate 0.5-3, bacillus subtilis is (containing breast
Acidfast bacilli, Bifidobacterium, saccharomycete) 0.05-3.5.
2. the symphysis unit feed addictive containing stachyose as described in claim 1, it is characterised in that produce the feed addictive
Stachyose include any stachyose for being extracted from Labiatae, Scrophulariaceae or legume.
3. the symphysis unit feed addictive containing stachyose as described in claim 1, it is characterised in that the feed addictive it is each
Composition weight proportioning is as follows：Yeast extract 20-35, inulin 15-20, laminarin 15-20, potassium butyrate 8-15, wheat bran 6-14,
Stachyose 3-7, cellulase 1-2, kilnitamin 1-2, protease 1-2, copper amino acid chelate 1-2, bacillus subtilis (contain
Bacillus acidi lactici, Bifidobacterium, saccharomycete) 0.5-2.
4. the symphysis unit feed addictive containing stachyose as described in claim 1, it is characterised in that each component of the Eco-fertilizer
Proportioning is as follows：Yeast extract 25, inulin 20, laminarin 18, potassium butyrate 12, wheat bran 10, stachyose 6, cellulase 2 mix
Close amino acid 2, protease 1, copper amino acid chelate 1.5, bacillus subtilis (containing Bacillus acidi lactici, Bifidobacterium, saccharomycete)
1.5。
5. the symphysis unit feed addictive containing stachyose as described in claim 1,2,3,4, it is characterised in that the feed adds
Agent can be used for all non-ruminant animals.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611202094.6A CN108236043A (en) | 2016-12-23 | 2016-12-23 | A kind of symphysis unit feed addictive containing stachyose |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611202094.6A CN108236043A (en) | 2016-12-23 | 2016-12-23 | A kind of symphysis unit feed addictive containing stachyose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108236043A true CN108236043A (en) | 2018-07-03 |
Family
ID=62703270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611202094.6A Pending CN108236043A (en) | 2016-12-23 | 2016-12-23 | A kind of symphysis unit feed addictive containing stachyose |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108236043A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1031379B1 (en) * | 2023-08-28 | 2024-09-18 | Hipeva | Synergistic composition comprising butyric acid and agave fructan |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101530165A (en) * | 2009-04-23 | 2009-09-16 | 上海谱莱生物技术有限公司 | Animal feed composite microecologic agent |
| US20120201796A1 (en) * | 2009-08-12 | 2012-08-09 | Vetcare Oy | Probiotic preparation for the prevention or treatment of canine gastrointestinal disorders |
| CN102870993A (en) * | 2012-10-10 | 2013-01-16 | 荆州双胞胎饲料有限公司 | Compound feed additive for effectively improving intestinal canal health of pigs |
| CN103082136A (en) * | 2013-01-15 | 2013-05-08 | 中北大学 | Pig feed additive |
| CN104381694A (en) * | 2014-11-29 | 2015-03-04 | 郑州后羿制药有限公司 | Composite microecological preparation |
-
2016
- 2016-12-23 CN CN201611202094.6A patent/CN108236043A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101530165A (en) * | 2009-04-23 | 2009-09-16 | 上海谱莱生物技术有限公司 | Animal feed composite microecologic agent |
| US20120201796A1 (en) * | 2009-08-12 | 2012-08-09 | Vetcare Oy | Probiotic preparation for the prevention or treatment of canine gastrointestinal disorders |
| CN102870993A (en) * | 2012-10-10 | 2013-01-16 | 荆州双胞胎饲料有限公司 | Compound feed additive for effectively improving intestinal canal health of pigs |
| CN103082136A (en) * | 2013-01-15 | 2013-05-08 | 中北大学 | Pig feed additive |
| CN104381694A (en) * | 2014-11-29 | 2015-03-04 | 郑州后羿制药有限公司 | Composite microecological preparation |
Non-Patent Citations (1)
| Title |
|---|
| 魏艳 等: "水苏糖-植物乳杆菌合生元对小鼠免疫功能的影响", 《中国食品学报》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1031379B1 (en) * | 2023-08-28 | 2024-09-18 | Hipeva | Synergistic composition comprising butyric acid and agave fructan |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103125773B (en) | Composite feed additive for restoring baby pig intestine mucosal injury | |
| CN104758318B (en) | A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate | |
| CN101530161B (en) | Novel feed additive and preparation method thereof | |
| Verdonk et al. | Application of inulin-type fructans in animal feed and pet food | |
| Hopwood et al. | Addition of pearl barley to a rice-based diet for newly weaned piglets increases the viscosity of the intestinal contents, reduces starch digestibility and exacerbates post-weaning colibacillosis | |
| CN102499326B (en) | Later-period piglet microbial fermentation antibiotics-free feed | |
| CN106619743A (en) | Probiotic solid drink with hypoglycaemic effect and preparation method of probiotic solid drink | |
| CN109527208A (en) | A kind of pet compound probiotic nutritional supplement | |
| US20090324761A1 (en) | Methods And Compositions for Improving Gastrointestinal Health | |
| CN102356828B (en) | Piglet early-stage microbial fermented antibiotic-free feed | |
| CN104605165A (en) | Compound feed additive replacing feed antibiotics in piglet daily diet, and applications of compound feed additive | |
| CN104397351A (en) | Biological antimicrobial-free feed additive and preparation method thereof | |
| CN102499325B (en) | Piglet microbial fermentation antibiotic-free creep feed | |
| CN102524539B (en) | Animal health preserver composition and preparation process for animal health preserver composition | |
| CN103392922A (en) | Compound feed additive capable of improving health level of animal | |
| CN103330059A (en) | Health care composition for livestock as well as preparation method and application thereof | |
| CN106922997A (en) | A kind of pig feed additive of efficient gastrointestinal mucosa repair function | |
| CN104206789A (en) | Feed additive for preventing cow mastitis and brucellosis and preparation method thereof | |
| CN110140971A (en) | A kind of water-soluble dietary fiber | |
| CN104543410B (en) | Disease-resistant pig feed additive of a kind of health care and preparation method thereof | |
| CN101297679A (en) | Feedstuff additive for improving immunity of livestock and poultry and preparation thereof | |
| CN104207151A (en) | Nutritional agent capable of promoting recovery of canine-feline intestinal function as well as preparation method and application of nutritional agent | |
| CN108902445A (en) | A kind of improvement intestine of young pigs health additive and preparation method thereof | |
| CN107712356A (en) | A kind of feed addictive and preparation method thereof, feed | |
| CN107173599A (en) | A kind of feed addictive for mitigating weaned piglet syndrome and preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180703 |